Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

To study hypoactive sexual desire disorder in a fragile X carrier female successfully treated with local testosterone application

International Journal of Impotence Research volume 20, pages 226–228 (2008)Cite this article

Abstract

There is still considerable controversy concerning the role of androgen therapy for hypoactive sexual desire disorder in females. Clinical trials have shown that exogenous testosterone therapy improves arousability, sexual desire and fantasy, frequency of sexual activity and orgasm, and satisfaction and pleasure from the sexual act. We report our experience of 36-year-old fragile X carrier female presented to our department with low sex drive and subjectively poor arousal for the past 1 year. We decided to treat her with local testosterone in a pump form (1% 5 g twice a week). She responded very well to the treatment, and in 3 weeks her libido and sexual functions improved dramatically. We decided to continue the same treatment for almost 1 year following up her free and total testosterone, complete lipid profiles, liver functions and complete blood picture every 3 months. During the whole course of treatment, she had mild facial acne, which was resolved in 2 months after completing treatment with testosterone. This is our first and only case of this syndrome with low sexual desire disorder treated with local testosterone in a pump form. Based upon our 1 year follow-up, low-dose testosterone is a safe and effective approach in treating hypoactive sexual desire disorder in a fragile X carrier female, provided the patient is monitored every 3 months for blood counts, lipid profiles, liver functions and free and total testosterone levels.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Jakiel G, Baran A . Androgen deficiency in women. Endokrynol Pol 2005; 56: 1016–1020.

    PubMed  Google Scholar 

  2. Bolour S, Braunstein G . Testosterone therapy in women: a review. Int J Impot Res 2005; 17: 399–408.

    Article  CAS  Google Scholar 

  3. Welt CK, Smith PC, Taylor AE . Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endocrinol Metab 2004; 89: 4569–4574.

    Article  CAS  Google Scholar 

  4. Warnock JK, Clayton A, Croft H, Segraves R, Biggs FC . Comparison of androgens in women with hypoactive sexual desire disorder: those on combined oral contraceptives (COCs) vs those not on COCs. J Sex Med 2006; 3: 878–882.

    Article  Google Scholar 

  5. Davis S, Davison S, Donath S, Bell R . Circulating androgen levels and self-reported sexual function in women. JAmMed Assoc 2005; 294: 91–96.

    Article  CAS  Google Scholar 

  6. Barton DL, Wender DB, Sloan JA . Sloan, Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3. J Natl Cancer Inst 2007; 99: 672–679.

    Article  CAS  Google Scholar 

  7. Phillips E, Bauman C . Safety surveillance of esterified estrogens-methyltestosterone (Estratest and Estratest HS) replacement therapy in the United States. Clin Ther 1997; 19: 1070–1084.

    Article  CAS  Google Scholar 

  8. Gelfand MM, Wiita B . Androgen and estrogen–androgen hormone replacement therapy: a review of the safety literature, 1941–1996. Clin Ther 1997; 19: 383–404.

    Article  CAS  Google Scholar 

  9. Davison SL, Davis SR . Androgens in women. J Steroid Biochem Mol Biol 2003; 85: 363–366.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, School of Medicine, New York University, New York, NY, USA,

    S Raza

  2. Department of Internal Medicine, New York Medical College (Our Lady of Mercy Medical Center), Bronx, New York, NY, USA,

    M Baig

  3. R-Endocrinology, Hamilton, NJ, USA

    J Ali

  4. Department of R-Endocrinology, UMDNJ-Robertwood Johnson Medical School, Hamilton, NJ, USA

    S Rizvi

Authors
  1. S Raza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Baig
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S Rizvi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Rizvi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Raza, S., Baig, M., Ali, J. et al. To study hypoactive sexual desire disorder in a fragile X carrier female successfully treated with local testosterone application. Int J Impot Res 20, 226–228 (2008). https://doi.org/10.1038/sj.ijir.3901611

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901611

Keywords

Search

Advanced search

Quick links